Parameters | No. | Mean ± SEM | P value |
---|---|---|---|
Norma Mucosa | 43 | 23.97 ± 4.106 | Mucosa vs. Dys 0.9522 |
Dysplasia (Dys) | 48 | 28.52 ± 4.661 | Mucosa vs. PH < 0.001 |
Primary HNSCC (PH) | 165 | 104.8 ± 6.823 | Dys vs. PH < 0.001 |
Grade | |||
 I | 43 | 49.84 ± 9.083 | I vs. II < 0.001 |
 II | 84 | 115.8 ± 9.275 | I vs. III < 0.001 |
 III | 38 | 142.8 ± 15.00 | II vs. III 0.2093 |
Lymph node involvement | |||
 N0 | 105 | 85.53 ± 7.646 | <0.001 |
 N1 + N2 | 60 | 138.6 ± 12.05 |  |
Tumor Size | |||
 T1 + T2 | 115 | 91.07 ± 7.109 | 0.002 |
 T3 + T4 | 50 | 136.5 ± 14.65 |  |
Gender | |||
 Male | 129 | 104.7 ± 7.607 | 0.9610 |
 Female | 36 | 105.5 ± 15.54 |  |
Age | |||
  < 50 | 44 | 98.84 ± 14.59 | 0.5976 |
  ≥ 50 | 121 | 107.0 ± 7.672 |  |
HPV infection | |||
 Negative | 149 | 102.0 ± 7.011 | 0.2017 |
 Positive | 16 | 131.5 ± 26.08 |  |
 Primary HNSCC (PH) | 165 | 104.8 ± 6.823 | (reference) |
 Recurrent HNSCC (Recurrence) | 12 | 170.2 ± 28.35 | 0.0144 |
 HNSCC with inductive TPF chemotherapy (post TPF) | 17 | 165.5 ± 18.40 | 0.0066 |